|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
This excerpt taken from the ABT 10-K filed Feb 22, 2006. (Income) from TAP Pharmaceutical Products Inc. Joint Venture Abbott's income from the TAP Pharmaceutical Products Inc. joint venture was lower in 2005 and 2004 compared to 2003 due to decreased sales due to market contraction for prescription proton pump inhibitors, and in 2004 by approximately $40 million as a result of an agreement with plaintiffs to settle litigation. This excerpt taken from the ABT 10-Q filed May 6, 2005. (Income) from TAP pharmaceutical Products Inc. Joint Venture Abbott's income from the TAP Pharmaceutical Products Inc. joint venture was lower in 2005 due to decreased sales due to continued market contraction for prescription proton pump inhibitors. This excerpt taken from the ABT 10-K filed Mar 2, 2005. (Income) From TAP Pharmaceutical Products Inc. Joint Venture Abbott's income from the TAP Pharmaceutical Products Inc. (TAP) joint venture was lower in 2004 and 2003 due to decreased sales due to market contraction for prescription proton pump inhibitors, and in 2004 by approximately $40 million as a result of an agreement with plaintiffs to settle litigation. | EXCERPTS ON THIS PAGE:
|
| |||||||